Be part of the knowledge.™

Spotlight On ATTR-CM

Welcome to Spotlight On ATTR-CM, your go-to source for the latest research, diagnostic advancements, and therapeutic strategies in transthyretin amyloid cardiomyopathy (ATTR-CM). Join leading cardiologists and researchers as they share their insights on this intricate condition to enhance patient care and outcomes.

0

LikeLikedUnlike

16-30 of 40

Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
AudioAbstracts
Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
- Hallie Blevins, PhD
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
Heart Matters
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
ATTR-CM Trials Revisited: A Broader View of Treatment Benefit
Heart Matters
ATTR-CM Trials Revisited: A Broader View of Treatment Benefit
From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
AudioAbstracts
From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
- Hallie Blevins, PhD
Managing Concomitant Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Evolving Care Strategies
AudioAbstracts
Managing Concomitant Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Evolving Care Strategies
- Marlene Mimi Maeusli, PhD.
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart Matters
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
advertisement
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart Matters
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
- Ryan Quigley
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart Matters
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
- Kevin Alexander, MD
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart Matters
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
- Kevin Alexander, MD
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart Matters
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Heart Matters
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart Matters
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
advertisement
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart Matters
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
- Ahmad Masri, MD, MS
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Heart Matters
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
- Ahmad Masri, MD, MS
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart Matters
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes

Program Chapters

Segment Chapters

Playlist:

Recommended